Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies

BACKGROUND. Trabectedin is reported as effective, especially against translocation‐related sarcomas (TRSs) after failure of or intolerance to standard chemotherapy. We conducted two phase II studies of TRS, confirming high efficacy of 1.2 mg/m(2) trabectedin. The updated data of 66 patients in these...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Takahashi, Mitsuru, Takahashi, Shunji, Araki, Nobuhito, Sugiura, Hideshi, Ueda, Takafumi, Yonemoto, Tsukasa, Morioka, Hideo, Hiraga, Hiroaki, Hiruma, Toru, Kunisada, Toshiyuki, Matsumine, Akihiko, Shimura, Masashi, Kawai, Akira
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2017
Предметы:
Sarcomas
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553952/
https://ncbi.nlm.nih.gov/pubmed/28526720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0064
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы